doi: 10.3389/fnut.2021.780205 Summary Keywords L-carnitine, COVID-19, SARS-CoV-2, pneumonia, infection Citation Badaro R, Barbosa JDV, de Araujo Neto CA, Machado BAS, Soares MBP, de Senna V, Taddeo M, de Arajo LT, Durkee S, Donninger R, Judge K and Saiyed Z (2023) A randomized clinical trial to evaluate the efficacy of L-carnitine L-tartrate to modulate the effects of SARS-CoV-2 infection
While glutathione IV therapy may help improve skin brightness and evenness in some individuals, results vary, and the treatment should be performed in a licensed clinic
Antidepressants are not recommended, although the combined tablet olanzapine-fluoxetine (Symbyax), which is not available in Denmark, is recommended as a second-line treatment for bipolar depression [12]
Pagano G, Manfredi C, Pallard FV, Lyakhovich A, Tiano L, Trifuoggi M (2021) Potential roles of mitochondrial cofactors in the adjuvant mitigation of pro-inflammatory acute infections, as in the case of sepsis and COVID-19 pneumonia